xonvea
exeltis baltics, uab - doksilamino-vandenilio sukcinatas/piridoksino hidrochloridas - modifikuoto atpalaidavimo tabletės - 20 mg/20 mg - doxylamine, combinations
thiopental vuab
lex ano, uab - tiopentalio natrio druska ir natrio karbonatas - milteliai injekciniam tirpalui - 1 g - thiopental
ketanov
sun pharmaceutical industries europe b. v. - ketorolako trometamolis - injekcinis tirpalas - 30 mg/ml - ketorolac
cyclodol
grindeks as - triheksifenidilio hidrochloridas - tabletės - 2 mg - trihexyphenidyl
methotrexat ebewe
ebewe pharma ges.m.b.h. nfg. kg - metotreksatas - injekcinis ar infuzinis tirpalas - 2,5 mg; 100 mg/ml; 10 mg/ml - methotrexate
ketorolac baxter
baxter holding b.v. - ketorolako trometamolis - injekcinis tirpalas - 30 mg/ml; 10 mg/ml - ketorolac
sarclisa
sanofi winthrop industrie - isatuximab - daugybinė mieloma - antinavikiniai vaistai - sarclisa is indicated: in combination with pomalidomide and dexamethasone, for the treatment of adult patients with relapsed and refractory multiple myeloma (mm) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor (pi) and have demonstrated disease progression on the last therapy. in combination with carfilzomib and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one prior therapy (see section 5.
ketorolac trometamol rompharm
tojaris projektai, uab - ketorolako trometamolis - injekcinis tirpalas - 30 mg/ml - ketorolac
cyclodol
niromed, uab - triheksifenidilio hidrochloridas - tabletės - 2 mg - trihexyphenidyl
haloperidol sopharma
tbs pharma - haloperidolis - injekcinis tirpalas - 5 mg/ml - haloperidol